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LBNPThe present study measured self-perceived thirst and plasma angiotensin II (ATII) concentrations during
graded hypovolaemic stress, induced by lower body negative pressure (LBNP), to elucidate the dependence
of thirst on haemodynamics. A total of 24 women aged between 20 and 36 (mean age, 23) years rated
their thirst on a visual analogue scale, graded from 0 to 100, when LBNP of 20, 30 and 40 mm Hg was applied.
Half of the women had a history of vasovagal syncope (VVS). The results showed that the thirst score in-
creased three-fold when LBNP was applied, from 11 (median; 25th–75th percentiles, 9–25) to 34 (27–53;
P b 0.001). The women in the VVS group had twice as great an increase as those without a history of VVS
(P b 0.02). The plasma ATII concentration increased signiﬁcantly in response to LBNP, both in the VVS group
and in the control group, but the changes did not correlate with thirst. Application of LBNP decreased systolic
and mean arterial pressures, cardiac output and pulse pressure (P b 0.001 for all), but thirst correlated only
with increase in heart rate and, independently, with reduction of mean arterial pressure. In conclusion, thirst
and ATII increase in response to hypovolaemic stress, but are not statistically related. The haemodynamic
parameter that was most strongly related to thirst was tachycardia.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. 1. Introduction
Thirst is a sensation that is aroused by a need for water, which is
crucial for maintaining homeostasis of the body ﬂuids [1,2]. High
osmolality is a known signal for thirst, and additional factors include
hypovolaemia and release of angiotensin II (ATII). Knowledge of the
aetiology of thirst is important for our understanding of how body
ﬂuid homeostasis is maintained and also enables us to treat thelty of Health Sciences, Linköping
72; fax: +46 855024671.
nc. Open access under CC BY license. excessive thirst that is a feature of certain disease states, such as
heart failure [3–5]. The current view of the relationship between ATII
and thirst is primarily based on animal studies [1,6,7], while human
thirst trials reveal a less clear picture [8]. Previous ﬁndings about the
role of AT II on the regulation of thirst are difﬁcult to generalize for
thirst in humans [7,9,10].
One situation in which increased thirst occurs is hypovolaemia, in
which blood volume is reduced, due to events such as bleeding,
pooling or dehydration. Hypovolaemia has profound effects on
venous ﬁlling, venous return, and cardiac output [11,12] and the re-
sponses may reveal different characteristics in individuals suffering
from vasovagal syncope (VVS) attacks [13]. Lower body negative
pressure (LBNP) is an excellent model for hypovolaemic circulatory
stress, as it induces central hypovolaemia and unloading of
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[12]. Orthostatic tolerance to LBNP is decreased in individuals with in-
duced hypovolaemia as well as in young women [14,29]. Low blood
volume might also play a role in the pathophysiology of VVS [15].
The ATII response to LBNP has not been studied in patients suffering
from VVS.
We therefore chose to study the sensation of thirst during
hypovolaemia in women suffering from recurrent VVS as well as in
womenwithout a history of syncope. Our aimwas to examine wheth-
er thirst increases during acute hypovolaemic stress and whether
ATII, haemodynamic parameters or a history of VVS can be statistical-
ly related to any inferred change.
2. Materials and methods
2.1. Volunteers
A total of 24 women, age between 20 and 36 (mean age 23) years
volunteered and participated in the study. Their mean (SD) body
height was 165 (6) cm, mean body weight was 63 (11) kg and mean
BMI was 23.0 (3.5) kg/m2. Three additional volunteers were excluded,
due tomissing data (n = 1) or to both objective and subjective signs of
presyncope during the protocol (n = 2). The participants had declared
themselves to be non-smokers and free from cardiopulmonary disease,
and were not taking medications that affect the cardiovascular system.
The volunteers were selected from two different cohorts; those
who had a history of VVS (VVS group) and those who had never
experienced syncope (control group). Eleven volunteers had previ-
ously been investigated due to clinically relevant syncope in daily
life, and had all been diagnosed with VVS during a positive tilt table
test. Moreover, they all had a negative cardiovascular examination
and were found otherwise healthy, ruling out cardiac syncope. The
women with VVS were recruited from a database in the Department
of Clinical Physiology in Linköping. The healthy controls were
recruited from the general population; they had never experienced
syncope and were matched regarding age and ﬁtness level.
All women were scheduled in the follicular phase (days 2–10) of
the menstrual cycle. Five women in the VVS group, but none in the
control group, were on oral contraceptives; similar studies conducted
in our laboratory have not detected any signiﬁcant impact of oral con-
traceptive use on cardiovascular ﬁndings [16]. All volunteers gave
written, informed consent to the experiments, which were approved
by the regional ethical review board in Linköping, in accordance with
the Declaration of Helsinki.
2.2. Procedure
The participants arrived at the Department of Clinical Physiology
at random, either in the morning or the afternoon, having had a
light meal 1 h prior to arrival. They had been instructed to abstain
from vigorous-intensity activity and beverages containing caffeine
for the 24 h preceding the experiments. To ensure optimal ﬂuid
balance typical for each volunteer, they were all instructed to drink
1 L of water on the evening prior to the experiments, allowing the
night time for excretion of excess ﬂuid.
The participants were not permitted to drink for 45 min prior to, as
well as during, the experiments, which were performed at a stable
room temperature of 25 °C. The study began after the participants
had rested in the supine position for 30 min to reach haemodynamic
steady-state. Immediately after the participant was placed in the
supine position, an indwelling catheter was inserted in the left
antecubital vein.
2.2.1. Lower body negative pressure
In the supine position, the lower part of the body up to the level of
the iliac crest, was enclosed in an airtight box with a seal ﬁttedhermetically around the waist [11]. The box was connected to a
vacuum source that permitted a stable negative pressure to be pro-
duced within 5 s and to be continuously measured with a rheostat.
Experiments were performed at LBNP of 0, 20, 30 and 40 mm Hg,
which were maintained for 4–5 min each. To assure return to the
basal state in blood pooled to the lower part of the body, blood pres-
sure and peripheral resistance, a break of 3–4 min between each
LBNP step was permitted.
2.3. Measurements
The measurements included assessment of thirst, blood sampling of
ATII and central haemodynamics at baseline and after application of
LBNP. Heart rate variability (HRV) was analysed from electrocardio-
gram (SphygmoCor®, AtCor Medical Pty Ltd, West Ryde, Australia)
recordings of heart rate.
2.3.1. Thirst
Perceived thirst intensity was assessed using a visual analogue
scale (VAS), which has previously been used to evaluate thirst in
patients with cancer, renal failure and heart failure, as well as during
trauma resuscitation [3–5,10]. The volunteers were informed just
before the experiments started that they would be asked to rate
their thirst sensation. They did not receive any information prior to
or during the experiments about thirst or that thirst intensity might
change.
The participants were asked to grade their thirst from ‘none’
(0 mm) to ‘worst possible’ (100 mm), by marking a cross at the
appropriate point on a 100 mm line. The volunteers were in the supine
position in the LBNP chamber and strapped down with equipment,
which meant that they were unable to move their arms. Therefore,
the researcher moved a pencil along the line and the volunteers stated
where on the line they wanted the cross to be placed. The researcher
who performed the thirst assessments during the experiments
had no preconceived stance on thirst or on the impact of LBNP on
thirst.
2.3.2. Angiotensin II
A venous blood sample for measurement of ATII was withdrawn
from each participant, at baseline and at the end of each 4-min period
of LBNP, in a cold anticoagulated tube. These sampleswere immediately
placed in an ice bath and cold centrifugedwithin 20 min of being taken.
The plasma samples were then stored at−70°C until analysed (Study
Centre, Clinical Chemistry, Karolinska University Laboratory, Stock-
holm, Sweden). The plasma concentration of ATII was measured with
a radio-immunological method after separation with Sep-Pak C-18
and incubation for approximately 24 h with antibodies from rabbit
directed against ATII. A trace amount of 125I-ATII was then added, and
the incubation continued for an additional 6 h. The bound and free
ATII were then separated using a second antibody directed against the
rabbit antibodies. After centrifugation and decanting, the 125I activity
was taken as themeasure of the plasma concentration of ATII. The coef-
ﬁcient of variation was 8.6% in the studied range.
2.3.3. Haemodynamics
Heart rate and arterial pressure were monitored non-invasively,
beat-by-beat (Finometer®Midi, FinapresMedical Systems, Amsterdam,
the Netherlands). A Vivid E-9 ultrasound scanner (GE Healthcare,
Wauwatosa, WI, USA) with a transthoracic 4 MHz probe and a
non-imaging 2.5 MHz Doppler probe was used to measure stroke vol-
ume. Prior to arrival at the laboratory, the participants had a routine
echo to rule out structural cardiac disease and to measure left ventricu-
lar (LV) size, ejection fraction, cardiac output and stroke volume, based
on the volume measurement according to Teichholz formula (Table 1).
During the experiments, each participant was in the supine position ﬂat
on her back, and itwas not always possible to obtain acceptable Doppler
Table 1






Age (years) 22.3 (2.3) 24.2 (5.3)
Length (cm) 167 (5) 164 (7)
Weight (kg) 64.4 (11.8) 61.5 (10.0)
BMI (kg/m2) 23.0 (4.0) 22.9 (3.0)
Cardiac output (L/min) 4.87 (0.98) 4.52 (1.2)
Stroke volume (mL/min) 74.8 (12.5) 67.4 (13.2)
Peripheral resistance (mm Hg min/L) 19.7 (4.2) 22.0 (6.9)
LVEDV 120 (18) 103 (21)
LVESV 45.1 (10.6) 38.5 (9.3)
Ejection fraction (%) 62.5 (5.7) 62.5 (3.6)
LV FS 0.34 (0.04) 0.34 (0.03)
Data are the mean (SD). None of the differences between the groups are statistically
signiﬁcant.
LVEDV: left ventricle end-diastolic volume; LVESV: left ventricle end-systolic volume;
LV FS: left ventricle fractional shortening.
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was measured from the suprasternal view (jugulum) using a non-
imaging probe. All measurements were conducted at the same phase
in the respiratory cycle (expiration). The recordings were carried out
at baseline, just prior to the start of each LBNP level and just prior to
LBNP termination. Two subsequent aortic outﬂow measurements,
whereby the probe was displaced in between, were conducted at each
point of measure to optimise the detection of the peak velocity integral.
The same individual conducted all measurements for both the VVS
group and the control group. During both subsequent aortic ﬂow mea-
surements, the valvular velocity time integral (VTI) was analysed dur-
ing three consecutive heart beats, and SV was calculated as the
sub-valvular area × VTI. Cardiac output was measured as the product
of heart rate and SV.2.3.4. HRV analysis
HRV analysis is a tool for use in the investigation of the sympathetic
and parasympathetic function of the autonomic nervous system
[17,18]. In the present study, the HRV analyses (frequency domains)
were conducted from continuous ECG recordings, using commercial
HRV software (SphygmoCor®, AtCor Medical Pty Ltd, West Ryde,
Australia), which assessed low frequency (LF), high frequency (HF),
LF/HF ratio, LF power normalised and HF power normalised, as well
as total power. At each LBNP step, the analysis included a division of
the power spectrum into LF (0.04–0.15 Hz) and HF (0.15–0.40 Hz)
bands. The reported parameters are the maximum low and high fre-
quencies (LFmax and HFmax), the normalised low and high frequency
power (LFpower and HFpower), the LF/HF ratio, and the total power.Fig. 1. Self-reported thirst (top) and plasma angiotensin II concentration (bottom)
before and after lower body negative pressure had been applied. Top: No group differ-
ence was seen at thirst level at baseline (P = 0.40). Thirst increased in both groups
with increasing LBNP (P b 0.001) and thirst increase was twice as high in VVS during
LBNP of 40 mm Hg (P b 0.02). Bottom: Plasma AT II concentrations increased with in-
creasing LBNP in both groups (P b 0.001) and were greater in VVS during LBNP of
40 mm Hg (P b 0.02). *Denotes comparisons between baseline values and LBNP
(Wilcoxon matched-pair test). *P b 0.05; **P b 0.01.2.4. Statistical analyses
Data having a normal distribution were reported as the mean and
standard deviation (SD), and differences between groups and over
time were measured by two-way repeated-measures analysis of var-
iance (ANOVA). Data showing a skewed distribution were given as
the median and 25th–75th percentile range. Changes over several
LBNP levels were compared by Friedman's test and over two levels
by the Wilcoxon matched-pair test, while differences between study
groups were measured with the Mann–Whitney U test. Stepwise
multiple regressions were used to scan correlations between the
key outcome measures and study parameters. Final evaluation of cor-
relations was made by simple and multiple linear regressions, after
logarithm-transformation of data showing a skewed distribution.
P b 0.05 was considered to be statistically signiﬁcant.3. Results
There were no statistically signiﬁcant demographic differences or
haemodynamic differences at baseline between the VVS group and
the control group (Table 1). All volunteers presented with normal
echocardiography and cardiac function at rest (Table 1).3.1. Thirst
The median (25th and 75th percentiles) thirst ratings at baseline
was similar in VVS and controls (10 (8–30) vs. 20 (9–27; P =
0.40)). Thirst increased gradually in response to LBNP (P b 0.001 for
all volunteers; Fig. 1, top), both in the control group (P b 0.001) and
in the VVS group (P b 0.01). Women with VVS had a greater increase
of thirst (median 20, 18–41) than the controls (median 10; 8–23;
P b 0.02).3.2. Angiotensin II
No group difference in plasma AT II concentration was seen at base-
line (Fig. 1, bottom). No difference was seen in baseline AT II concen-
tration in VVS group on oral contraceptives (n = 5) compared to VVS
women not using oral contraceptives (n = 6; P = 0.29). The plasma
AT II concentration increased in response to LBNP (P b 0.001 for all
volunteers) and was generally higher among volunteers in the VVS
group than in the control group (median 11.5 pmol/L, 7.5–18.5 vs.
7.5, 5.9–11.5; P b 0.001). The ﬁnal AT II concentration was signiﬁcantly
higher in the VVS group than in the control group (P b 0.02).
37N. Waldréus et al. / Physiology & Behavior 120 (2013) 34–39The increase in plasma ATII primarily occurred in a non-linear
fashion after application of LBNP of 30 mm Hg; the pooled plasma
AT II concentration at 0–20 mm Hg was median 6.9 (6.2–11.2)
pmol/L, compared to 10.0 (7.5–16.3) pmol/L at 30–40 mm Hg
(P b 0.01).
No correlation between thirst and the ATII concentration was
found.
3.3. Haemodynamics
The arterial systolic, mean and pulse pressures and cardiac output
all decreased with increasing LBNP level (P b 0.001), with no systemat-
ic differences between the study groups. A trend towards a greater
decrease in pulse pressure with increasing LBNP level was seen in
VVS (P = 0.06). Compared to rest, pulse pressure decreased already
at application of LBNP of 20 mm Hg in VVS (P = 0.05), while it did
not decrease until LBNP of 30 mm Hg in controls (P = 0.60 in controls
at LBNP 20 mm Hg; Fig. 2). Furthermore, pulse pressure was lower at
LBNP of 40 mm Hg in VVS compared to controls (P = 0.03; Fig. 2).
Heart rate increased gradually with increasing LBNP in both groups
(P b 0.001; Fig. 2). Compared to rest, heart rate was signiﬁcantly in-
creased already during LBNP of 20 mm Hg in VVS (P = 0.006), while
heart rate was not signiﬁcantly increased in controls until LBNP of
30 mm Hg was applied (Fig. 2).
Analyses based on all four points in time showed that thirst corre-
lated most positively with heart rate (Fig. 3A). A multiple linear
regression showed an inversely and independent correlation with
thirst and mean arterial pressure (r = 0.47, P b 0.001). In these re-
gression analyses, VVS did not serve as a statistically signiﬁcant
co-factor.
3.4. HRV analysis
LFpower and the LF/HF ratio increased, while HFmax and HFpower
decreased in response to LBNP (P b 0.001) (Table 2). There were no
statistically signiﬁcant differences in HRV parameters between the
study groups, but the rise in LF/HF ratio was observed ﬁrst at greater
hypovolaemic stress in the VVS group (Fig. 3B).Fig. 2. Arterial pressure, heart rate and cardiac output before and during LBNP. Comparison
parisons between baseline values and LBNP. *P b 0.05; **P b 0.01; ***P b 0.001. Pulse pressHeart rate correlated positively with LF/HF ratio (r = 0.50,
P b 0.001; Fig. 3C). Of the components of this ratio, heart rate corre-
lated positively with LF power (r = 0.44, P b 0.001).
4. Discussion
Hyperosmolality caused by water deprivation is the most well-
established stimulus for thirst in humans, but there is abundant
evidence to suggest that other mechanisms also are involved. The pres-
ent study used induced short bouts of hypovolaemic stress to investi-
gate possible relationships between thirst, ATII and haemodynamic
factors in this setting. We also included volunteers with a history of
VVS, with the aim of improving understanding of the interplay be-
tween the thirst signal and haemodynamics.
Self-perceived thirst score increased three-fold for all volunteers
when LBNP of 40 mm Hg was applied and was doubled in women
prone to VVS compared to the controls. The results also show that
the plasma concentration of ATII almost doubled when hypovolaemia
was induced by LBNP. Group trends show that thirst gradually
increased when LBNP was raised, while ATII rose ﬁrst during LBNP
levels of 30 mm Hg and above (Fig. 1), which is in agreement with
the ﬁndings of Tidgren et al. [19]. At this time, heart rate increased
in both groups, while arterial pressures and cardiac output remained
virtually unchanged (Fig. 2). This is consistent with the role that the
renin–angiotensin system plays in maintaining haemodynamics in
hypovolaemic states. A modulating role for ATII in haemodynamics
is further suggested by the generally higher plasma concentrations
that were observed in the participants with a history of VVS, seeming-
ly with greater decrease in pulse pressure as well as increased heart
rate already at a lower LBNP level (Fig. 2).
Multiple regression analysis identiﬁed two haemodynamic factors
that correlated with thirst. The most important of these was the heart
rate, which acts to maintain cardiac output during hypovolaemia. How-
ever, tachycardia does not always occur in response to haemorrhage
[20], and is a poor index of hypovolaemia during surgery [21]. The
increase of LH/HF ratio with heart rate supports the theory that the
tachycardia was due to sympaticovagal imbalance [17,18].
Thirst increased with reduced mean arterial pressure, which sup-
ports evidence suggesting that arterial baroreceptors arouse the thirsts are made with repeated measures ANOVA followed by Dunnett's test. *Denotes com-
ure was lower in VVS compared to controls during LBNP of 40 mm Hg (P b 0.05).
Fig. 3. Selected correlations between thirst, heart rate and heart rate variability were tested with linear regression analysis. LF/HF ratio = low frequency power divided by high
frequency power.
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womenwith VVS with seemingly greater hypovolaemia than the con-
trols, at least at LBNP of 40 mm Hg (Figs. 1 and 2). Interestingly, there
was a poor overall correlation, or none at all, between thirst and more
direct indices of hypovolaemia, such as pulse pressure and cardiac
output. Furthermore, the overall linear correlations between thirst
and haemodynamics were not very strong, indicating that factors
other than those identiﬁed here are of importance to perceived thirst.
Besides the effects of hypovolaemia, the most important stimulation
for thirst is an increase of the osmotic pressure in plasma that affects
the thirst centre in the brain. The intracellular decrease of body ﬂuid
might also cause dry mouth that can be associated with pronounced
thirst.
The view that ATII increases thirst has often been proposed in
medical textbooks, but remains poorly supported in humans. AT II is
the physiological response to a decrease in blood volume and water
and salt are needed to restore the volume. Because of this interaction,
it can be difﬁcult to comprehend the role of hypovolaemia and AT II
on thirst. In acute trauma, evidence for mechanistic interplay be-
tween thirst and ATII was recently sought by a linear regression anal-
ysis that was based on individual participants, rather than on group
mean values [10]. These analyses did not disclose any inter-
correlation. However, both the thirst sensation and ATII concentra-
tion gradually increased with hypovolaemia. One study in male
volunteers reported that thirst increased in a similar way on infusion
of ATII or saline; nevertheless, there was a statistically signiﬁcant
linear correlation between changes in thirst and plasma ATII in a sub-
group of four volunteers who drank more water than the other study
participants after the infusion [8]. Drinking water was shown to
decrease ATII in another study in humans [23].
The method we used for inducing circulatory stress (LBNP) creates
central hypovolaemia which unloads low- and high-pressure barore-
ceptors, and overall hypovolaemic circulatory stress is increased in a
linear fashion with increasing LBNP levels [12]. In the present studyTable 2
Heart rate variability analysis before lower body negative pressure was applied and when
Controls
0 mm Hg 40 mm Hg
LFmax (Hz) 0.09 (0.08–0.11) 0.06 (0.05–
HFmax (Hz) 0.26 (0.21–0.31) 0.19 (0.16–
LF/HF ratio 1.14 (0.69–1.82) 3.44 (2.16–
LFpower (Hz) 53 (39–64) 78 (68–8
HFpower (Hz) 47 (36–61) 23 (19–3
Total power (kHz) 5.3 (1.9–7.0) 2.9 (1.7–6
Data are the median and 25th–75th percentiles. LFmax and HFmax = maximum low and hig
LFpower and HFpower = normalised low and high frequency power, respectively.
Signiﬁcance levels are *P b 0.05 and **P b 0.01.it is of interest that LBNP of 10–20 mm Hg displaces 400–550 mL of
blood to the lower part of the body [24,25], while LBNP of 30–
40 mm Hg concomitantly displaces 500–1000 mL [12,26], equivalent
to mild and moderate haemorrhage, respectively [12]. Low levels of
LBNP (up to 15–20 mm Hg) activate mainly cardiopulmonary low-
pressure receptors in healthy subjects, leading to increased peripher-
al sympathetic nervous system outﬂow, even in the absence of
changes in arterial blood pressure or heart rate (Fig. 2), while higher
levels of LBNP decreased arterial blood pressure and affected high-
pressure arterial baroreceptors (Fig. 2) [27,28]. Thus, thirst seems to
increase even before high-pressure arterial baroreceptors are
deactivated (Fig. 1).
The participants in the present study were included on the basis of
two different criteria; absence or presence of VVS. It has been stipu-
lated that low blood volume could play a role in the pathophysiology
behind VVS, at least to some extent [15]. LBNP tolerance is markedly
reduced in individuals with hypovolaemia, induced either by furose-
mide [14] or controlled venesection of 500 mL of blood before onset
of LBNP [29]. Therefore, we found it intriguing to study the effects
of hypovolaemia on ATII and thirst in both healthy individuals and
women suffering from recurrent syncope. Women with VVS had a
greater increase in thirst sensation when LBNP of 40 mm Hg was
applied, primarily because of lesser thirst at baseline, with no differ-
ence observed in thirst level at LBNP of 40 mm Hg (Fig. 1). No group
differences were observed in any blood pressure parameters at rest.
However, the VVS group experienced greater central hypovolaemia
and an earlier deactivation of arterial baroreceptors in response to
LBNP, as pulse pressure decreased to a larger extent in VVS (Fig. 2),
further corroborated by the fact that two women with VVS did not
complete the protocol due to subjective and/or objective signs of
presyncope (not included in the study due to missing data). Further-
more, heart rate increased signiﬁcantly in VVS at lower hypovolaemic
stress than controls which is in line with the greater increase in thirst
during LBNP in VVS (Figs. 1 and 2).negative pressure had been raised to 40 mm Hg.
Vasovagal syncope
0 mm Hg 40 mm Hg
0.10)* 0.08 (0.05–0.11) 0.07 (0.06–0.09)
0.22)* 0.24 (0.18–0.28) 0.18 (0.16–0.19)
4.19)** 1.25 (0.65–2.31) 2.85 (2.41–3.59)*
1)** 56 (39–69) 74 (70–78)*
2)** 44 (31–61) 26 (22–30)*
.2) 3.8 (1.8–6.0) 2.6 (1.2–3.1)
h frequencies, respectively.
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lality was not measured. However, the study period was fairly short
and, in the absence of manipulations of ﬂuid balance in addition to
evaporation and blood sampling, there is little reason to believe that
the gradually increasing thirst was due to hyperosmolality. Our
study focused on thirst during hypovolaemic stress when LBNP was
applied. We tried to ensure sufﬁcient hydration with water intake
the evening before the experiments. A second issue is that LBNP levels
were not randomised. Although ATII has a very short half-life, only
one measurement was made at each LBNP level, making it unclear
as to whether the maximum concentration had been reached.
5. Conclusion
hypovolaemic stress increased thirst and plasma ATII concentra-
tions in a non-linear fashion. Thirst correlated with tachycardia, LF/HF
ratio and reduction of mean arterial pressure. Volunteers with a history
of vasovagal syncope showed pronounced thirst and ATII responses
than participants without a history of syncope.
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